Your browser doesn't support javascript.
loading
Fabrication, characterization and in vivo assessment of cardiogel loaded chitosan patch for myocardial regeneration.
Sharma, Vineeta; Manhas, Amit; Gupta, Santosh; Dikshit, Madhu; Jagavelu, Kumaravelu; Verma, Rama Shanker.
Afiliação
  • Sharma V; Stem Cell and Molecular Biology Laboratory, Bhupat and Jyoti Mehta School of Biosciences, Department of Biotechnology, Indian Institute of Technology-Madras, Chennai 600036, TN, India.
  • Manhas A; PCS-202, Pharmacology Division, CSIR-Central Drug Research Institute, Lucknow 226031, UP, India; Academy of Scientific and Innovative Research, Ghaziabad 201002, UP, India.
  • Gupta S; Stem Cell and Molecular Biology Laboratory, Bhupat and Jyoti Mehta School of Biosciences, Department of Biotechnology, Indian Institute of Technology-Madras, Chennai 600036, TN, India.
  • Dikshit M; PCS-202, Pharmacology Division, CSIR-Central Drug Research Institute, Lucknow 226031, UP, India; Translational Health Science and Technology Institute, Faridabad 121001, Haryana, India.
  • Jagavelu K; PCS-202, Pharmacology Division, CSIR-Central Drug Research Institute, Lucknow 226031, UP, India; Academy of Scientific and Innovative Research, Ghaziabad 201002, UP, India. Electronic address: kumaraveluj@cdri.res.in.
  • Verma RS; Stem Cell and Molecular Biology Laboratory, Bhupat and Jyoti Mehta School of Biosciences, Department of Biotechnology, Indian Institute of Technology-Madras, Chennai 600036, TN, India; Department of Biotechnology, Motilal Nehru National Institute of Technology, Allahabad, Prayagraj, 21104 UP, India.
Int J Biol Macromol ; 222(Pt B): 3045-3056, 2022 Dec 01.
Article em En | MEDLINE | ID: mdl-36243159
ABSTRACT
Cell therapy is one of the promising approaches for cardiac repair, subsequently after infarction or injury. However, contemporary mesenchymal stromal/stem cell (MSCs) delivery strategies result in low retention and poor engraftment of donor cells, thus limiting the therapeutic efficacy. Here, we developed an engineered biomimetic cardiogel patch (EBCP) comprising of the native decellularized cardiac extracellular matrix (ECM) "cardiogel" and chitosan, leading to the efficient regeneration of injured myocardium. We also developed novel bio-adhesive that is capable of suture-free epicardial placement of EBCP to injured myocardium. We have illustrated the potential of the mussels-inspired bioadhesive system, which comprises gelatin catechol and partially oxidized chitosan, which relies on self-crosslinking capability, to promote wet adhesion. In vitro studies with isolated cardiogel promoted cell proliferation, adhesion, and migration while aiding cardiomyogenic differentiation. The EBCP's ability to protect cells from abrasion due to surrounding tissues in the myocardial infarction (MI) rat model makes it more desirable. Furthermore, the epicardial implantation of the EBCP loaded with MSCs improves the initial retention of cells and subsequent functional cardiac recovery with enhanced myocardial tissue restoration. Histological examination showed the presence of EBCP and infiltration of cells to the infarcted heart tissue. The fast and facile synthesis of bioadhesive and major therapeutic benefits of EBCP make it a potential candidate for recuperating the ailing heart.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Quitosana / Células-Tronco Mesenquimais / Infarto do Miocárdio Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Quitosana / Células-Tronco Mesenquimais / Infarto do Miocárdio Idioma: En Ano de publicação: 2022 Tipo de documento: Article